The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global internal trauma fixation device market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Internal trauma fixation devices refer to the biologically inert medical tools implanted for the stabilization of fractured bones in the body. Some of the commonly used devices include cannulated screws, intramedullary nails, hip screws, cables, wires, plates and pins. They are manufactured using stainless steel, tritium, nitinol, polyether ether ketone (PEEK), nickel and titanium and are corrosion resistant and adjustable according to the bone structure. They aid in maintaining the original shape of the bone and facilitate repair by restricting the movement of fractured bones. As a result, they are widely used across hospitals, orthopedic surgical centers and trauma and ambulatory centers.
The increasing prevalence of orthopedic disorders, along with the rising geriatric population across the globe, is one of the key factors driving the growth of the market. Moreover, the rising incidence of road accidents and sports-related injuries are providing a thrust to the market growth. The internal trauma fixation devices are widely used for elderly patients, which are more prone to fractures and joint dislocation due to osteoporosis and other bone-related disorders. This has further led to the increasing adoption of biocompatible, elastic and fatigue and kink-resistant closure devices, which is also contributing to the market growth. In line with this, the increasing adoption of minimally invasive (MI) surgical procedures for the placement of internal trauma fixation devices is favoring the growth of the market. Additionally, various innovations in implant technologies and the development of cement-augmented transiliacal internal fixators are acting as other growth-inducing factors. These devices provide improved stabilization of fractures in the pelvis. Other factors, including the rising healthcare expenditure capacities of the masses, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global internal trauma fixation device market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, material and end user.
Breakup by Product:
Breakup by Material:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., B. Braun Melsungen AG, Globus Medical Inc., Johnson & Johnson Private Limited, Medartis AG, Orthofix Medical Inc., Orthopaedic Implant Company, OsteoMed (Berkshire Hathaway Inc.), Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Material, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Arthrex Inc., B. Braun Melsungen AG, Globus Medical Inc., Johnson & Johnson Private Limited, Medartis AG, Orthofix Medical Inc., Orthopaedic Implant Company, OsteoMed (Berkshire Hathaway Inc.), Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at